The professor of neurology at Johns Hopkins Medicine provided an in-depth look at the 2022 RNDS and the unique design it offers patients with rare neuroimmune disorders. [WATCH TIME: 3 minutes]
Carlos A. Pardo-Villamizar, MD
Advertisement
Articles by Carlos A. Pardo-Villamizar, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
2
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
3
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
4
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
5
